A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants
Clinical trial NCT06890611 · COMPLETED
Trial details
- NCT number
- NCT06890611
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-25
- Primary completion
- 2025-09-26
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.